Patents by Inventor Lingyi Cai

Lingyi Cai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220235357
    Abstract: The present subject matter relates to the use of one or more inhibitors to treat a disease, e.g., cancer, in a subject. The presently disclosed subject matter provides for compositions and methods for treating a subject using a cancer transition inhibitor, an inhibitor that reduces the expression level of a marker of the transition of adipose-derived stromal cells (ASCs) to COL11A1-expressing cancer-associated fibroblasts (CAFs).
    Type: Application
    Filed: December 28, 2021
    Publication date: July 28, 2022
    Applicants: The Trustees of Columbia University in the City of New York, The University of Texas Health Science Center at Houston
    Inventors: Dimitris Anastassiou, Lingyi Cai, Kaiyi Zhu, Mikhail Kolonin